Title: Functional gastrointestinal disorders in infancy: recommendations to pragmatic management
| Published: | 2018 |
Pharmacists play a critical role in supporting parents on the topic of early life nutrition. In the Pharmaceutical Society of Australia (PSA) conference, Dr Thomas Ludwig the Principal Scientist of Paediatric Gastroenterology from Nutricia Research explained the role of nutrition as the first-line of management for the common functional gastrointestinal disorders (FGIDs) in infants, based on the evidence and according to the international recommendations.
Click this video (the conference record), aiming to:
- Discuss the current evidence and guidelines regarding gastrointestinal disorders in infants and early life nutrition
- Understand the nutrition first approach to align evidence with condition
- Recommend appropriate treatment, provide patient support and recommendations based on current guidelines for gastrointestinal disorders in infancy.
For Pharmaceutical Society of Australia (PSA) accreditation, please log in to:
https://my.psa.org.au/s/training-plan/a117F000001A3bt/functional-gastrointestinal-disorders-in-infancy
Accreditation Code: CPSA1834A
About PSA
Pharmaceutical Society of Australia is the peak national professional pharmacy organisation to lead and support innovative and evidence-based healthcare service delivery by pharmacists. It represents Australia’s 30,000 pharmacists working in all sectors and across all locations.